ArticleACS sensors2025
Improving Real-Time In Vivo Molecular Monitoring: Multi-Gaussian with Laplacian Voltammogram Fitting Enhances the Precision of Electrochemical Aptamer-Based Sensors.
Article in ACS sensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Minimally Invasive, Subcutaneous Biosensor Reliably Estimates Plasma Methotrexate Exposure and Quantifies Plasma-to-Tissue Transport Kinetics.ACS pharmacology & translational science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Electrochemical, aptamer-based (EAB) sensors are the first technology supporting high-frequency, real-time measurements of the concentrations of specific drugs, metabolites, and biomarkers in the body that is independent of the chemical reactivity of its analytes. To achieve this, EAB sensors employ the binding-induced folding of an electrode-attached, redox-reporter-modified aptamer to produce an electrochemical output easily monitored using square wave voltammetry. Using such sensors, multiple research groups have achieved the seconds-resolved, multihour measurement of multiple drugs and metabolites in situ in the veins, brains, and peripheral solid tissues of live animals. Historically, the large volume of voltammograms (hundreds per hour) produced by in vivo EAB sensors have been fitted using simple polynomials to extract the peak heights from which target concentrations are estimated. This, however, can lead to misestimation of peak heights due to overfitting of noise or poor correction of peak shouldering. In response, here we describe an alternative method of fitting EAB sensor voltammograms that improves the accuracy of "problematic" (i.e., noisy, or heavily "shouldered") data sets while simultaneously reducing sensor noise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.